144 - December 23, 2025
Brief
Rocket Lab Director Edward H. Frank, through Fidelity Brokerage Services, has filed a Form 144 to sell 2,500 shares of common stock. The intended sale, valued at approximately $193,471.75, is scheduled for December 23, 2025, and will occur on the NASDAQ.
Detailed Brief
This Form 144 filing signals an insider action by Rocket Lab Director Edward H. Frank. He has notified the SEC of his intention to sell 2,500 shares of the company's common stock, acquired via restricted stock vesting on September 2, 2023, as compensation. The planned sale, brokered by Fidelity Brokerage Services, has an aggregate market value of $193,471.75 and is slated for December 23, 2025, on the NASDAQ exchange. The filing includes an attestation that the seller is unaware of any material adverse information regarding the issuer's current or prospective operations that has not been publicly disclosed.
Key Telemetry
- • Insider Sale: Director Edward H. Frank plans to sell 2,500 common shares.
- • Sale Value: Aggregate market value of the proposed sale is $193,471.75.
- • Acquisition Basis: Shares were acquired through restricted stock vesting on 09/02/2023 as compensation.
- • Sale Date: The approximate date of sale is set for 12/23/2025.
- • No Prior Sales: No securities of the issuer were sold by the reporting person in the past 3 months.
Impact Vector
This Form 144 filing is solely a notice of intent for a single director to sell a small number of shares, representing less than 0.0005% of outstanding common stock. It does not provide insights into Rocket Lab's operational performance, launch cadence, revenue trajectory, or strategic development like Neutron. The sale is an isolated insider transaction and does not materially impact the company's launch capabilities, orbital expansion plans, or overall market positioning. Investors should look to quarterly earnings reports (10-Q) or other current reports (8-K) for operational and financial intelligence.